DK30092A - Fremgangsmaade og midler til ikke-invasiv aedosis-til-virkningae administration af lipofile laegemidler - Google Patents
Fremgangsmaade og midler til ikke-invasiv aedosis-til-virkningae administration af lipofile laegemidler Download PDFInfo
- Publication number
- DK30092A DK30092A DK030092A DK30092A DK30092A DK 30092 A DK30092 A DK 30092A DK 030092 A DK030092 A DK 030092A DK 30092 A DK30092 A DK 30092A DK 30092 A DK30092 A DK 30092A
- Authority
- DK
- Denmark
- Prior art keywords
- patient
- lollipop
- methods
- aedosis
- lipofile
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Otolaryngology (AREA)
- Zoology (AREA)
- Obesity (AREA)
- Communicable Diseases (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1989/003801 WO1991003233A1 (en) | 1989-09-05 | 1989-09-05 | Method and compositions for noninvasive dose-to-effect administration of lipophilic drugs |
US8903801 | 1989-09-05 |
Publications (3)
Publication Number | Publication Date |
---|---|
DK30092D0 DK30092D0 (da) | 1992-03-05 |
DK30092A true DK30092A (da) | 1992-05-05 |
DK175773B1 DK175773B1 (da) | 2005-02-14 |
Family
ID=22215208
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK199200300A DK175773B1 (da) | 1989-09-05 | 1992-03-05 | Fremgangsmåde og midler til ikke-invasiv "dosis-til-virkning" administration af lipofile lægemidler |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0493380B1 (da) |
JP (1) | JP2758985B2 (da) |
AT (1) | ATE159658T1 (da) |
AU (2) | AU645966B2 (da) |
DE (1) | DE68928415T2 (da) |
DK (1) | DK175773B1 (da) |
NO (2) | NO920854L (da) |
WO (1) | WO1991003233A1 (da) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH624011A5 (da) * | 1977-08-05 | 1981-07-15 | Battelle Memorial Institute | |
EP0745380B1 (en) * | 1995-05-11 | 2005-08-03 | University Of Utah Research Foundation | Tobacco substitute |
US20060051413A1 (en) * | 2004-09-08 | 2006-03-09 | Chow Sing S M | Method of enhancing absorptions of transmucosal administration formulations |
US7776831B2 (en) * | 2006-02-01 | 2010-08-17 | Weg Stuart L | Use of antifungal compositions to treat upper gastrointestinal conditions |
US20160022643A1 (en) * | 2014-07-22 | 2016-01-28 | Professional Compounding Centers Of America | Oral Transmucosal Compositions including Aromatase Inhibitors for Low Testosterone Levels in Men |
US10525099B2 (en) | 2014-10-01 | 2020-01-07 | Oxytone Bioscience B.V. | Orally disintegrating solid pharmaceutical dosage unit containing a partus control substance |
HUE051974T2 (hu) | 2014-10-01 | 2021-04-28 | Oxytone Bioscience B V | Szájban szétesõ, szülést szabályozó ágenst tartalmazó, szilárd halmazállapotú gyógyászati dózisegység |
GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
EP3955918A1 (en) | 2019-04-17 | 2022-02-23 | COMPASS Pathfinder Limited | Methods of treating neurocognitive disorders, chronic pain and reducing inflammation |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2208120A (en) * | 1938-03-02 | 1940-07-16 | William B Coleman | Pharmaceutical preparation and method of making same |
US3943928A (en) * | 1974-09-25 | 1976-03-16 | Lariccia Anthony H | Eliminating the safety hazard in oral dissolution of a solid |
CA1208558A (en) * | 1982-10-07 | 1986-07-29 | Kazuo Kigasawa | Soft buccal |
US4551329A (en) * | 1984-01-20 | 1985-11-05 | Joan Harris | Oral medicament lollipop |
US4671953A (en) * | 1985-05-01 | 1987-06-09 | University Of Utah Research Foundation | Methods and compositions for noninvasive administration of sedatives, analgesics, and anesthetics |
-
1989
- 1989-09-05 DE DE68928415T patent/DE68928415T2/de not_active Expired - Lifetime
- 1989-09-05 EP EP90902584A patent/EP0493380B1/en not_active Expired - Lifetime
- 1989-09-05 WO PCT/US1989/003801 patent/WO1991003233A1/en active IP Right Grant
- 1989-09-05 AT AT90902584T patent/ATE159658T1/de not_active IP Right Cessation
- 1989-09-05 AU AU50352/90A patent/AU645966B2/en not_active Ceased
- 1989-09-05 JP JP2502779A patent/JP2758985B2/ja not_active Expired - Lifetime
-
1992
- 1992-03-04 NO NO92920854A patent/NO920854L/no unknown
- 1992-03-04 NO NO92920855A patent/NO920855L/no unknown
- 1992-03-05 DK DK199200300A patent/DK175773B1/da not_active IP Right Cessation
-
1994
- 1994-04-27 AU AU60697/94A patent/AU6069794A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
NO920854L (no) | 1992-04-27 |
AU6069794A (en) | 1994-06-23 |
DK30092D0 (da) | 1992-03-05 |
EP0493380A1 (en) | 1992-07-08 |
WO1991003233A1 (en) | 1991-03-21 |
NO920855D0 (no) | 1992-03-04 |
DK175773B1 (da) | 2005-02-14 |
DE68928415D1 (de) | 1997-12-04 |
EP0493380B1 (en) | 1997-10-29 |
AU645966B2 (en) | 1994-02-03 |
JP2758985B2 (ja) | 1998-05-28 |
ATE159658T1 (de) | 1997-11-15 |
DE68928415T2 (de) | 1998-02-26 |
EP0493380A4 (en) | 1992-10-07 |
NO920855L (no) | 1992-04-10 |
NO920854D0 (no) | 1992-03-04 |
AU5035290A (en) | 1991-04-08 |
JPH05501854A (ja) | 1993-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Bowles et al. | Evaluation of new gingival retraction agents | |
Kennedy et al. | Intravenous regional analgesia: an appraisal | |
DE69003392D1 (de) | Dosisform zur oralen verabreichung des hypoglykämischen glipizids. | |
ATE113203T1 (de) | Darreichnungsform zur verabreichnung eines antiparkinsonsmittel. | |
UY26425A1 (es) | Formulación y método antidiabético | |
NL990012I2 (nl) | Geneesmiddelen die salmeterol en fluticason bevatten. | |
DE69002718T2 (de) | Medikamente. | |
DK30092D0 (da) | Fremgangsmaade og midler til ikke-invasiv aedosis-til-virkningae administration af lipofile laegemidler | |
MXPA02003495A (es) | Derivados de piridinio para el manejo de complicaciones vasculares diabeticas y relacionadas con la edad, proceso para su preparacion, y usos terapeuticos de los mismos. | |
Bloom et al. | Clinical evaluation of prazosin as the sole agent for the treatment of hypertension: A double-blind cross-over study with methyldopa. | |
IL112288A (en) | Use of riluzole in the manufacture of a medicament for the treatment of mitochondrial diseases | |
ATE89737T1 (de) | Behandlung von leukozytstoerungen mit gm-csf. | |
BR9708388A (pt) | Solução aquosa de hemoglobina polimerizada piridoxilada e processo de sua preparação. | |
Snir et al. | Central venous stasis retinopathy following the use of tranexamic acid | |
Sugai et al. | Sequential changes in the fade of tetanic tension after the administration of tubocurarine in anaesthetized man | |
Clement | Effect of indoramin on finger blood flow in vasospastic patients | |
EP0397211A3 (en) | Percutaneous administration of 3'-azide-3'-deoxythymidine | |
Reynolds et al. | Circulatory versus respiratory deaths from pentothal sodium | |
CN2233753Y (zh) | 护心袋 | |
RU94018748A (ru) | Лекарственный сбор для лечения больных с нарушениями сердечного ритма | |
Samuels et al. | Regional anesthesia for the emergency department physician | |
Wilbert | Drug Intoxication: An Economic Waste and a Menace to Public Health | |
RU94019564A (ru) | Способ лечения желудочно-кишечных заболеваний | |
CN1174914A (zh) | 防治呼吸道疾病的药物纸巾 | |
Woods | Sedation for dental treatment of infants. II. Clinical procedure |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUP | Patent expired |